Experimental HBsAg/anti-HBs complex assay for prediction of HBeAg loss in chronic hepatitis B patients treated with pegylated interferon and adefovir

A de Niet; L Jansen; H Zaaijer; U Klause; B Takkenberg; HLA Janssen; T Chu; R Petric; HW Reesink

Experimental HBsAg/anti-HBs complex assay for prediction of HBeAg loss in chronic hepatitis B patients treated with pegylated interferon and adefovir

A de Niet, L Jansen, H Zaaijer, U Klause, B Takkenberg, HLA Janssen, T Chu, R Petric, HW Reesink

Gastroenterology & Hepatology

Research output: Contribution to journal › Article › Academic › peer-review

11 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	259-267
Number of pages	9
Journal	Antiviral Therapy
Volume	19
Issue number	3
Publication status	Published - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{3995c5e07e2947cf82cdd36e13bd4d1f,

title = "Experimental HBsAg/anti-HBs complex assay for prediction of HBeAg loss in chronic hepatitis B patients treated with pegylated interferon and adefovir",

author = "{de Niet}, A and L Jansen and H Zaaijer and U Klause and B Takkenberg and HLA Janssen and T Chu and R Petric and HW Reesink",

year = "2014",

language = "Undefined/Unknown",

volume = "19",

pages = "259--267",

journal = "Antiviral Therapy",

issn = "1359-6535",

publisher = "International Medical Press Ltd",

number = "3",

}

TY - JOUR

T1 - Experimental HBsAg/anti-HBs complex assay for prediction of HBeAg loss in chronic hepatitis B patients treated with pegylated interferon and adefovir

AU - de Niet, A

AU - Jansen, L

AU - Zaaijer, H

AU - Klause, U

AU - Takkenberg, B

AU - Janssen, HLA

AU - Chu, T

AU - Petric, R

AU - Reesink, HW

PY - 2014

Y1 - 2014

M3 - Article

VL - 19

SP - 259

EP - 267

JO - Antiviral Therapy

JF - Antiviral Therapy

SN - 1359-6535

IS - 3

ER -